当前位置: X-MOL 学术J. Sep. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Poly-pharmacokinetic strategy represented the synergy effects of bioactive compounds in a traditional Chinese medicine formula, Si Shen Wan and its separated recipes to normal and colitis rats
Journal of Separation Science ( IF 3.1 ) Pub Date : 2021-03-15 , DOI: 10.1002/jssc.202001258
Lu Liu 1 , Shi Wang 1 , Qing-Xia Xu 1 , Wei Xu 1 , You-Bo Zhang 1 , Xiu-Wei Yang 1
Affiliation  

Si Shen Wan is a classic traditional Chinese medicine formula, which has been used to treat chronic colitis for thousands of years. Many research and experience show that Si Shen Wan was developed by the combination of two sets of “Herb Pairs,” Er Shen Wan and Fructus Schisandrae Chinensis Powder. This research aimed to revealing the effective substances, guide the clinical treatment, and represent the synergy effects from the view of pharmacokinetics. An ultra high performance liquid chromatography with tandem mass spectrometry method was established and validated for simultaneous quantification of 26 main bioactive compounds in normal and colitis rat plasma after oral administration of Si Shen Wan and its “Herb Pairs” extract. The method validation results illustrated that the experimental method was reliable and reproducible for quantitative determination of the biological samples. The pharmacokinetic behaviors in different groups were compared and discussed comprehensively, which indicated that the treatment of Si Shen Wan has a superiority in synthetic action of the “Herb Pairs” for the higher peak concentrations and bioavailability of some mainly components. Furthermore, the synergy effect was still existing backed up again for the longer eliminate time and a better bioavailability in colitis groups. The pharmacokinetics research of multiple components in Si Shen Wan and its “Herb Pairs” supplied a significant basis for better understanding the metabolic mechanism of these formulas in both normal and pathological state.

中文翻译:

多药代动力学策略代表中药方剂四神丸及其分离方中生物活性化合物对正常和结肠炎大鼠的协同作用

四神丸是经典的中药方剂,用于治疗慢性结肠炎已有数千年历史。许多研究和经验表明,四神丸是由二神丸和五味子散两套“成药对”组合而成。本研究旨在揭示有效物质,指导临床治疗,从药代动力学的角度代表协同作用。建立并验证了超高效液相色谱串联质谱法,用于同时定量四神丸及其“草本对”提取物后正常和结肠炎大鼠血浆中的 26 种主要生物活性化合物。方法验证结果表明,该实验方法对于生物样品的定量测定是可靠且可重复的。对不同组间的药代动力学行为进行综合比较和讨论,表明四神丸治疗在“成药对”的合成作用方面具有优越性,部分主要成分的峰浓度和生物利用度较高。此外,由于结肠炎组的消除时间更长和生物利用度更好,协同效应仍然存在。四神丸及其“成药对”中多种成分的药代动力学研究为更好地了解这些方剂在正常和病理状态下的代谢机制提供了重要依据。对不同组间的药代动力学行为进行综合比较和讨论,表明四神丸治疗在“成药对”的合成作用方面具有优越性,部分主要成分的峰浓度和生物利用度较高。此外,由于结肠炎组的消除时间更长和生物利用度更好,协同效应仍然存在。四神丸及其“成药对”中多种成分的药代动力学研究为更好地了解这些方剂在正常和病理状态下的代谢机制提供了重要依据。对不同组间的药代动力学行为进行综合比较和讨论,表明四神丸治疗在“成药对”的合成作用方面具有优越性,部分主要成分的峰浓度和生物利用度较高。此外,由于结肠炎组的消除时间更长和生物利用度更好,协同效应仍然存在。四神丸及其“成药对”中多种成分的药代动力学研究为更好地理解这些方剂在正常和病理状态下的代谢机制提供了重要依据。说明四神丸处理具有较高的峰浓度和某些主要成分的生物利用度,在“成药对”的合成作用上具有优势。此外,由于结肠炎组的消除时间更长和生物利用度更好,协同效应仍然存在。四神丸及其“成药对”中多种成分的药代动力学研究为更好地理解这些方剂在正常和病理状态下的代谢机制提供了重要依据。说明四神丸处理具有较高的峰浓度和某些主要成分的生物利用度,在“成药对”的合成作用上具有优势。此外,由于结肠炎组的消除时间更长和生物利用度更好,协同效应仍然存在。四神丸及其“成药对”中多种成分的药代动力学研究为更好地理解这些方剂在正常和病理状态下的代谢机制提供了重要依据。
更新日期:2021-03-15
down
wechat
bug